Process View
Any process that modulates the frequency, rate or extent of endothelial cell apoptotic process.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of endothelial cell apoptotic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.947 | ||
| SQSTM1 | sequestosome 1 | 0.930 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.912 | ||
| AKR1C2 | aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) | 0.906 | Human | |
| VEGFA | vascular endothelial growth factor A | 0.819 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.800 | Mouse | |
| AKR1C1 | aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) | 0.755 | Human | |
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.729 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.727 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.684 | Human | |
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.677 | ||
| FGA | fibrinogen alpha chain | 0.673 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.671 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.663 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.649 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.626 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.615 | ||
| FGB | fibrinogen beta chain | 0.611 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.600 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.571 | ||
| TRAF5 | TNF receptor-associated factor 5 | 0.534 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.510 | ||
| MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) | 0.490 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.438 | ||
| KEAP1 | kelch-like ECH-associated protein 1 | 0.435 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.428 | Mouse | |
| AXL | AXL receptor tyrosine kinase | 0.425 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.409 | Human | |
| AKR1C3 | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | 0.360 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.351 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.305 | ||
| LAT | linker for activation of T cells | 0.303 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.295 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.292 | ||
| FGG | fibrinogen gamma chain | 0.284 | ||
| TRAF6 | TNF receptor-associated factor 6 | 0.264 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.263 | ||
| TNFRSF6B | tumor necrosis factor receptor superfamily, member 6b, decoy | 0.259 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.240 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.228 | ||
| TNF | tumor necrosis factor | 0.219 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.206 | ||
| PLAU | plasminogen activator, urokinase | 0.180 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.171 | ||
| EGFR | epidermal growth factor receptor | 0.168 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.155 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.143 | ||
| TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | 0.143 | Human | |
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.138 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.135 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.134 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.127 | ||
| PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.126 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.126 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.125 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.121 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.116 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.115 | ||
| NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 | 0.112 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.110 | ||
| PLAT | plasminogen activator, tissue | 0.109 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.100 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.099 | ||
| PRKCZ | protein kinase C, zeta | 0.096 | Human | |
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.092 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.086 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.086 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.080 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.078 | ||
| ANGPT2 | angiopoietin 2 | 0.077 | Human | |
| CRP | C-reactive protein, pentraxin-related | 0.071 | ||
| VIM | vimentin | 0.071 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.069 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.068 | ||
| SYK | spleen tyrosine kinase | 0.067 | ||
| TRADD | TNFRSF1A-associated via death domain | 0.067 | ||
| S100B | S100 calcium binding protein B | 0.065 | ||
| ENG | endoglin | 0.065 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.065 | ||
| MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.064 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.062 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.058 | ||
| LAPTM5 | lysosomal protein transmembrane 5 | 0.057 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.056 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.055 | ||
| CDCP1 | CUB domain containing protein 1 | 0.055 | ||
| ANGPT1 | angiopoietin 1 | 0.054 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.054 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.052 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.051 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.049 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.048 | ||
| SPRR2A | small proline-rich protein 2A | 0.048 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.046 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.045 | ||
| KITLG | KIT ligand | 0.045 | ||
| TNIP1 | TNFAIP3 interacting protein 1 | 0.043 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.042 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.041 | ||
| MAP2K5 | mitogen-activated protein kinase kinase 5 | 0.040 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.040 | ||
| MAPT | microtubule-associated protein tau | 0.039 | ||
| FN1 | fibronectin 1 | 0.039 | ||
| BGN | biglycan | 0.039 | ||
| KSR1 | kinase suppressor of ras 1 | 0.039 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.039 | ||
| ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | 0.039 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.038 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.035 | Human | |
| PCOLCE | procollagen C-endopeptidase enhancer | 0.034 | ||
| BACH1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | 0.033 | Human | |
| FYB | FYN binding protein | 0.033 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.033 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.032 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.032 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.032 | ||
| APP | amyloid beta (A4) precursor protein | 0.032 | ||
| VEGFC | vascular endothelial growth factor C | 0.031 | ||
| ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.031 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.030 | ||
| SMAD3 | SMAD family member 3 | 0.030 | ||
| EMILIN1 | elastin microfibril interfacer 1 | 0.030 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.029 | ||
| CD2 | CD2 molecule | 0.029 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.028 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.028 | ||
| TTR | transthyretin | 0.028 | ||
| COL6A2 | collagen, type VI, alpha 2 | 0.028 | ||
| SH2D1A | SH2 domain containing 1A | 0.028 | ||
| ORM1 | orosomucoid 1 | 0.028 | ||
| PRKCE | protein kinase C, epsilon | 0.027 | ||
| CARD11 | caspase recruitment domain family, member 11 | 0.026 | ||
| ZNF71 | zinc finger protein 71 | 0.025 | ||
| ILK | integrin-linked kinase | 0.025 | ||
| PRKCA | protein kinase C, alpha | 0.024 | ||
| IL32 | interleukin 32 | 0.024 | ||
| CD14 | CD14 molecule | 0.024 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.023 | ||
| KIAA1377 | KIAA1377 | 0.023 | ||
| C1orf93 | chromosome 1 open reading frame 93 | 0.023 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.022 | ||
| ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0.022 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.022 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.022 | ||
| CD34 | CD34 molecule | 0.021 | ||
| TBX2 | T-box 2 | 0.021 | ||
| ATXN1 | ataxin 1 | 0.021 | ||
| SPHK1 | sphingosine kinase 1 | 0.021 | ||
| TRAF3IP2 | TRAF3 interacting protein 2 | 0.020 | ||
| ZFAND5 | zinc finger, AN1-type domain 5 | 0.020 | ||
| SOS2 | son of sevenless homolog 2 (Drosophila) | 0.020 | ||
| ACTB | actin, beta | 0.020 | ||
| PDGFC | platelet derived growth factor C | 0.020 | ||
| BANP | BTG3 associated nuclear protein | 0.020 | ||
| CLDN5 | claudin 5 | 0.020 | ||
| NBR1 | neighbor of BRCA1 gene 1 | 0.019 | ||
| VWF | von Willebrand factor | 0.019 | ||
| TNFSF14 | tumor necrosis factor (ligand) superfamily, member 14 | 0.019 | Human | |
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.019 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.019 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.018 | ||
| PGF | placental growth factor | 0.018 | ||
| TECPR1 | tectonin beta-propeller repeat containing 1 | 0.018 | ||
| APOA1 | apolipoprotein A-I | 0.018 | ||
| LDLR | low density lipoprotein receptor | 0.018 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.017 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.017 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.017 | ||
| KLF13 | Kruppel-like factor 13 | 0.017 | ||
| PEBP4 | phosphatidylethanolamine-binding protein 4 | 0.017 | ||
| DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | 0.017 | ||
| F2 | coagulation factor II (thrombin) | 0.017 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.017 | ||
| PICK1 | protein interacting with PRKCA 1 | 0.017 | ||
| CCDC115 | coiled-coil domain containing 115 | 0.017 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.017 | ||
| OSMR | oncostatin M receptor | 0.017 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.017 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.016 | ||
| VTN | vitronectin | 0.016 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.016 | ||
| MAP2 | microtubule-associated protein 2 | 0.016 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.016 | ||
| PRKCQ | protein kinase C, theta | 0.016 | Human | |
| MAPK8 | mitogen-activated protein kinase 8 | 0.016 | ||
| MAFK | v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) | 0.016 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.016 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.016 | ||
| AEBP1 | AE binding protein 1 | 0.016 | ||
| FABP4 | fatty acid binding protein 4, adipocyte | 0.016 | ||
| TANK | TRAF family member-associated NFKB activator | 0.016 | ||
| NUMB | numb homolog (Drosophila) | 0.015 | ||
| PML | promyelocytic leukemia | 0.015 | ||
| PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.015 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.015 | ||
| CALCRL | calcitonin receptor-like | 0.015 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.015 | ||
| FRZB | frizzled-related protein | 0.015 | ||
| PRKCB | protein kinase C, beta | 0.015 | ||
| TSC2 | tuberous sclerosis 2 | 0.015 | ||
| COL18A1 | collagen, type XVIII, alpha 1 | 0.014 | Mouse | |
| NNMT | nicotinamide N-methyltransferase | 0.014 | ||
| PTPRE | protein tyrosine phosphatase, receptor type, E | 0.014 | ||
| SHANK3 | SH3 and multiple ankyrin repeat domains 3 | 0.014 | ||
| NRP1 | neuropilin 1 | 0.014 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.014 | ||
| PPP1R14A | protein phosphatase 1, regulatory (inhibitor) subunit 14A | 0.014 | ||
| ZBTB16 | zinc finger and BTB domain containing 16 | 0.014 | ||
| ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 0.013 | ||
| CCL14 | chemokine (C-C motif) ligand 14 | 0.013 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.013 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.013 | ||
| HDAC6 | histone deacetylase 6 | 0.013 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.013 | Human | |
| IL4R | interleukin 4 receptor | 0.013 | ||
| PLXDC1 | plexin domain containing 1 | 0.013 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.013 | ||
| CSF1R | colony stimulating factor 1 receptor | 0.013 | Human | |
| RAI14 | retinoic acid induced 14 | 0.012 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.012 | ||
| TNC | tenascin C | 0.012 | ||
| IL15RA | interleukin 15 receptor, alpha | 0.012 | ||
| KLF5 | Kruppel-like factor 5 (intestinal) | 0.012 | ||
| GJA4 | gap junction protein, alpha 4, 37kDa | 0.012 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.012 | Human | |
| STAB1 | stabilin 1 | 0.012 | ||
| A2M | alpha-2-macroglobulin | 0.012 | ||
| ADAM19 | ADAM metallopeptidase domain 19 | 0.012 | ||
| DARC | Duffy blood group, chemokine receptor | 0.012 | ||
| POLH | polymerase (DNA directed), eta | 0.012 | ||
| BAD | BCL2-associated agonist of cell death | 0.012 | ||
| CSNK1A1 | casein kinase 1, alpha 1 | 0.012 | ||
| KLF1 | Kruppel-like factor 1 (erythroid) | 0.012 | ||
| STK10 | serine/threonine kinase 10 | 0.012 | ||
| FLNA | filamin A, alpha | 0.011 | ||
| RARRES2 | retinoic acid receptor responder (tazarotene induced) 2 | 0.011 | ||
| GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.011 | Human | |
| MCAM | melanoma cell adhesion molecule | 0.011 | ||
| PXN | paxillin | 0.011 | ||
| TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 0.011 | ||
| ITK | IL2-inducible T-cell kinase | 0.011 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.011 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.011 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.011 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.011 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.011 | ||
| ALB | albumin | 0.011 | ||
| STRN | striatin, calmodulin binding protein | 0.011 | ||
| THBD | thrombomodulin | 0.011 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.011 | ||
| CD93 | CD93 molecule | 0.011 | ||
| NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | 0.011 | ||
| TAB2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | 0.011 | ||
| HAND2 | heart and neural crest derivatives expressed 2 | 0.011 | ||
| APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | 0.011 | ||
| FBLN2 | fibulin 2 | 0.011 | ||
| TRIM9 | tripartite motif containing 9 | 0.010 | ||
| HSD3B7 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | 0.010 | ||
| STC1 | stanniocalcin 1 | 0.010 | ||
| ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 | 0.010 | Mouse | |
| PCDH12 | protocadherin 12 | 0.010 | ||
| SLMAP | sarcolemma associated protein | 0.010 | ||
| ASGR2 | asialoglycoprotein receptor 2 | 0.010 | ||
| BAG1 | BCL2-associated athanogene | 0.010 |